INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

82,071 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$364K
2,663 sh
Jan 26, 2026
Page 1661 of 2052
← PrevNext →
Jan 27, 2026
traded Jan 26, 2026
+1d
SEC Form 4

Evidence

9
MT
Munsey Joshua ToddChief Financial Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$47K
203 sh
Jan 24, 2026Jan 27, 2026
traded Jan 24, 2026
+3dSEC Form 4

Evidence

9
KH
Kass HunterCo-President and RMD
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Disposition to issuer
D—
11.2K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
MB
Murray BrianDirector
BTGOBITGO HOLDINGS, INC.
Derivative conversion
C—
1,675 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
KE
Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Disposition to issuer
D—
1,120 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
FR
Foger Jenna R.EVP - Co-Lead - Life Science
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Disposition to issuer
D—
1,120 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
CH
Cole John HartCo-President, & Co-RMD
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Tax withholding
F$11K
176 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
CH
Cole John HartCo-President, & Co-RMD
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Disposition to issuer
D—
1,759 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
HD
Hersman DeborahDirector
LYFTLyft, Inc.
Grant or award
A—
4,842 sh
Jan 25, 2026Jan 27, 2026
traded Jan 25, 2026
+2dSEC Form 4

Evidence

9
HJ
Hakman JosephCo-Chief Operating Officer
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Disposition to issuer
D—
1,759 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
ET
Evans Allan ThomasDirector, Chief Executive Officer
UMACUnusual Machines, Inc.
Grant or award
A—
220.0K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
LS
Lepori StephanieCAO & Chief Admin. Officer
CZRCaesars Entertainment, Inc.
Grant or award
A—
38.7K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
CJ
Cooper William J.Chief Legal Officer/ Secretary
SMRNUSCALE POWER Corp
Grant or award
A—
27.2K sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

9
PP
Pelosi PeggieDirector
EXPIAGNT, Inc.
Grant or award
A—
5,258 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

9
FD
Fasanella DavidEVP
NFBKNorthfield Bancorp, Inc.
Tax withholding
F$18K
1,535 sh
Jan 24, 2026Jan 27, 2026
traded Jan 24, 2026
+3dSEC Form 4

Evidence

9
TP
Thiara ParvinderDirector
ZURAZura Bio Ltd
Grant or award
A—
38.8K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

9
SD
Schick John DouglasDirector, President and CEO
PEDPEDEVCO CORP
Tax withholding
F$45K
76.1K sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

9
RM
Ramani MohitChief Risk Officer
KEYKEYCORP /NEW/
Option exercise
M—
61.5K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

7
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
51.9K sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$131K
950 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

6
BM
Boyd William M IIIChief Strategy Officer
SYMSymbotic Inc.
Option exercise
M—
2,910 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$131K
951 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

5
KJ
Kuffner JamesCHIEF TECHNOLOGY OFFICER
SYMSymbotic Inc.
Grant or award
A—
61.4K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
HJ
Howe JolandaSVP, GLOBAL CONTROLLER
MIRMMirum Pharmaceuticals, Inc.
Option exercise
M—
1,500 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
KJ
Kuffner JamesCHIEF TECHNOLOGY OFFICER
SYMSymbotic Inc.
Grant or award
A—
30.7K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
MA
Modi Rajeev A.SEE REMARKS
ELANElanco Animal Health Inc
Grant or award
A$1,415
58 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
TJ
Twomey Cormac JEVP, Global Ops & Delivery
CNXCConcentrix Corp
Tax withholding
F$12K
292 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

5
AT
Alsbrook Madeleine ThorpEVP - Talent Management
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Tax withholding
F$7,760
130 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
FG
Freve Maria GSee Remarks
SYMSymbotic Inc.
Grant or award
A—
13.8K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
AT
Alsbrook Madeleine ThorpEVP - Talent Management
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Disposition to issuer
D—
1,120 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

5
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$802K
51.9K sh
Jan 27, 2026Jan 27, 2026
traded Jan 27, 2026
+0dSEC Form 4

Evidence

5
HE
Horn Daniel E.Chief Commercial Officer
AMRAlpha Metallurgical Resources, Inc.
Tax withholding
F$46K
198 sh
Jan 24, 2026Jan 27, 2026
traded Jan 24, 2026
+3dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$6,652
50 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$6,652
50 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

2
BM
Boyd William M IIIChief Strategy Officer
SYMSymbotic Inc.
Grant or award
A—
30.7K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

2
BM
Boyd William M IIIChief Strategy Officer
SYMSymbotic Inc.
Option exercise
M—
8,826 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

2
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$126K
8,135 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

2
BM
Boyd William M IIIChief Strategy Officer
SYMSymbotic Inc.
Grant or award
A—
15.3K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence